Nader Yatim, Matthew L. Albert  Immunity 

Slides:



Advertisements
Similar presentations
Apoptosis By Douglas R. Green
Advertisements

APOPTOSIS Pathway of cell death in which cells activate enzymes that degrade the cells’ own nuclear DNA and nuclear and cytoplasmic proteins.
Cross-talking between autophagy and viral infection in mammalian cells Hongya HAN;Lishu ZHANG ;Xinxian DAI;Yanpeng ZHENG; College of Life Sciences & Bioengineering,
Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects  Chi Chen, Ah-Ng Tony Kong  Trends in Pharmacological.
Interferons: Type I José Ignacio Saldana, Imperial College London, UK
Cutting Edge in IFN Regulation: Inflammatory Caspases Cleave cGAS
Causes, effects and molecular mechanisms of testicular heat stress
Cellular and Molecular Mechanisms of Liver Injury
Volume 31, Issue 3, Pages (September 2009)
Regulation of inflammasomes by autophagy
Bridget A. Robinson, Timothy J. Nice  Immunity 
Cellular and Molecular Mechanisms of Liver Injury
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner  Hans-Joachim Anders, Maciej.
How cells die: Apoptosis pathways
Figure 1 Regulation of key antiviral responses in pancreatic β cells
Agnieszka Kaczmarek, Peter Vandenabeele, Dmitri V. Krysko  Immunity 
Mechanism and Regulation of NLRP3 Inflammasome Activation
Pyroptosis Current Biology
Dieter Demon, Lieselotte Vande Walle, Mohamed Lamkanfi 
On the TRAIL to Overcome BRAF-Inhibitor Resistance
Pseudokiller, Qu’est-ce que C’est?
Pathogen Recognition and Innate Immunity
The Many Roles of FAS Receptor Signaling in the Immune System
Autophagy, Apoptosis, and the Influenza Virus M2 Protein
Filling a GAP(DH) in Caspase-Independent Cell Death
Volume 3, Issue 6, Pages (June 2008)
Volume 44, Issue 1, Pages 9-16 (October 2011)
Staying Alive: Cell Death in Antiviral Immunity
Joshua E. Allen, Wafik S. El-Deiry  Gastroenterology 
Douglas R. Green, Beth Levine  Cell 
Autophagy in the Pathogenesis of Disease
John G. Monroe, Mary E. Keir  Immunity 
Lucifer's Labyrinth—Ten Years of Path Finding in Cell Death
Mitochondria in the Regulation of Innate and Adaptive Immunity
Anti-inflammatory Agents: Present and Future
An Inflammatory Perspective on Necroptosis
The cGAS-STING Defense Pathway and Its Counteraction by Viruses
Dangerous Liaisons: Mitochondrial DNA Meets the NLRP3 Inflammasome
A matter of life and death
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
Inflammasomes in Intestinal Inflammation and Cancer
Death receptor-mediated apoptosis and the liver
Superficial Immunity: Antimicrobial Responses Are More Than Skin Deep
Roles of Caspases in Necrotic Cell Death
Taro Kawai, Shizuo Akira  Immunity  Volume 34, Issue 5, Pages (May 2011)
Mario Cortese, Charles Sinclair, Bali Pulendran  Cell Metabolism 
Cytosolic Sensing of Viruses
Manipulation of Host Cell Death Pathways during Microbial Infections
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
Inflammasome Complexes: Emerging Mechanisms and Effector Functions
Innate Recognition of Viruses
Innate Immunity: Cytoplasmic DNA Sensing by the AIM2 Inflammasome
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Greg J. Towers, Mahdad Noursadeghi  Cell Host & Microbe 
DNA Makes RNA Makes Innate Immunity
Mechanisms and Functions of Inflammasomes
Getting a gRIP on Flu by Casting the DAI
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Jun-Young Seo, Rakina Yaneva, Peter Cresswell  Cell Host & Microbe 
Intracellular NOD-like Receptors in Host Defense and Disease
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Joseph A. Trapani, Phillip I. Bird  Immunity 
The End and After: How Dying Cells Impact the Living Organism
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
Macrophages, Immunity, and Metabolic Disease
“Bak (and Bax) to the Future” — of Primary Melanoma Prognosis?
Autophagy and the Integrated Stress Response
Volume 31, Issue 3, Pages (September 2009)
The Many Roles of FAS Receptor Signaling in the Immune System
Presentation transcript:

Dying to Replicate: The Orchestration of the Viral Life Cycle, Cell Death Pathways, and Immunity  Nader Yatim, Matthew L. Albert  Immunity  Volume 35, Issue 4, Pages 478-490 (October 2011) DOI: 10.1016/j.immuni.2011.10.010 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Virus Entry and Replication Is Interconnected with Cell survival and Cell Death Pathways After influenza A (IVA) entry, intrinsic cell stress triggers host cell death pathways. An early phase of viral protein expression results in a counterbalance to the activation of apoptosis. NS1 expression activates PI3kAkt pathway, leading to survival signals and the coincident downregulation of proapoptotic factors (e.g., Caspase-3). Additionally, autophagy enhances cell survival through the removal of damaged cellular components and through the direct inhibition of cell death. During late phase of IVA infection, M2-mediated inhibition of autophagosome maturation results in abortive autophagy and increased cellular stress due to accumulation of damaged organelles and unfolded proteins. Moreover, PB1-F2 expression triggers mitochondrial outer membrane permeabilization (MOMP) via a still disputed mechanism that may involve Bax, VDAC, and/or ANT1. This combination of events results in caspase activation, which appears to facilitate maturation and release of mature virions. Immunity 2011 35, 478-490DOI: (10.1016/j.immuni.2011.10.010) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Schematic Representation of the Phases of Influenza Infection Early phase influenza (IVA) infection is marked by autophagy and inhibition of apoptosis. As a result of dendritic cell (DC) infection, there is rapid activation of IVA-specific CD8+ T cells, but a subset of this response (at least in experimental models) appears to be counterprotective. During late-phase infection, abortive autophagy and direct action of IVA gene products coordinate the induction of apoptotis. This contributes to enhanced cross-priming, which favors the expansion of protective CD8+ T cells. We propose that the enhanced cellular immune response may participate in the transmission phase by provoking programmed reflexes such as coughing and sneezing, thus spreading IVA. Immunity 2011 35, 478-490DOI: (10.1016/j.immuni.2011.10.010) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Integrating the Effect of Influenza Viral Proteins on Endosomal and Cytosolic Innate Immune Sensors During viral replication, single-stranded RNA may be delivered to the endosome via the autophagy-mediated sequestration of cytosolic material, thus permitting the engagement of Toll-like receptor 7 (TLR7). TLR7 in turn recruits Myd88, which results in the nuclear translocation of IRF7 and NFκB and the induction of type I interferons and proinflammatory cytokines and/or chemokines, respectively. In the case of the latter, this response includes the expression of pro-IL1β and pro-IL18 (signal 1 for inflammasome-mediated inflammation). Viral replication generates 5′-ppp-genome that is recognized by RIG-I, an upstream sensor that recruits IPS-1 to the mitochondrial outer membrane via a CARD-like domain and may inhibit Bcl2 antiapoptotic effects. Activation of IRF3 via TBK1- and IKKε-dependent phosphorylation results in expression of additional proinflammatory and antiviral host factors. IPS-1 also activates NFκB via FADD- and RIPK1-dependent pathways with possible crosstalk to cell death pathways via caspase-8 and/or RIPK3 possibly leading to apoptosis or necroptosis. Production of M2 viral protein inhibits autophagosomal maturation, thus having a potential effect on TLR7 and/or RIG-I. Additionally, M2 activates the NLRP3 inflammasome via a mechanism dependent on its proton channel activity (signal 2). NLRP3 oligomerization activates caspase-1 via the adaptor protein ASC, resulting in the maturation and secretion of Il1β and Il18. Caspase-1 may also induce pyroptosis, which has been reported to be inhibited by NS-1 via still unknown mechanisms. Immunity 2011 35, 478-490DOI: (10.1016/j.immuni.2011.10.010) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Cytomegalovirus Entry Results in the Reprogramming of Multiple Cell Death Programs Cellular infection by cytomegalovirus (CMV) results in a rapid activation of inflammation and stress pathways. The latter engages BH3-only proteins and establishes a pro-apoptotic pressure on the host cell. Counterbalancing these stimuli, CMV encodes for specific inhibitors for Bax activation, referred to as viral mitochondrial localized inhibitor of apoptosis (vMIA), and, in the case of mouse CMV, an viral inhibitor of Bak oligomerization (vIBO). Inflammation also engages extrinsic pathways for apoptosis. The viral inhibitor of caspase activation (vICA) serves to inhibit caspase-8 protease activity, but has the consequence of simultaneously sensitizing the cell to necroptosis. Hence, a fourth regulator of cell death (to date identified in mouse but not human CMV), the viral inhibitor of RIPK activation (vIRA), perturbs RIPK1 and RIPK3 interaction via its RHIM domain. Immunity 2011 35, 478-490DOI: (10.1016/j.immuni.2011.10.010) Copyright © 2011 Elsevier Inc. Terms and Conditions